/ EXAS
Exact Sciences Spikes After Abbott Reveals Massive $23B Buyout Agreement
Exact Sciences surged more than 17% premarket after Abbott announced a $23 billion buyout, adding Cologuard and Oncotype DX to its diagnostics lineup.
November 20, 2025Exact Sciences surged more than 17% premarket after Abbott announced a $23 billion buyout, adding Cologuard and Oncotype DX to its diagnostics lineup.
November 20, 2025